Navigation Links
Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar
Date:12/27/2010

MORRISTOWN, N.J., Dec. 27, 2010 /PRNewswire/ -- Vicus Therapeutics, LLC, today announced the initiation of a Phase 2 trial evaluating VT-122, a novel investigational combination of etodolac and propranolol, and Nexavar® (sorafenib) tablets, as a potential new treatment option for patients with advanced liver cancer (hepatocellular carcinoma), systemic inflammation and cachexia.  

The randomized, open label, multi-center Phase 2 study will evaluate whether VT-122 in combination with Nexavar increases "Clinical Benefit Response," which is a composite measurement of pain, performance status, and lean body mass, as compared to Nexavar alone.  The secondary efficacy endpoints of this study are cancer and cachexia specific symptoms, duration of Nexavar therapy and overall survival.

The study will be conducted under Vicus' US IND and is expected to enroll 80 patients with advanced liver cancer, systemic inflammation and cachexia at multiple sites in the United States.  Enrollment into this study is expected to be completed by the end of 2011. For more information about enrolling in the study, please visit www.clinicaltrial.gov.

Vicus Therapeutics, LLC, Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. have entered into an agreement pursuant to which Bayer and Onyx have agreed to support the study. The terms of the agreement are confidential.

About Cancer-induced Systemic Inflammation and Cachexia

The most common trajectory of the cancer patient is local progression, development of metastases, cancer-induced systemic inflammation and the associated symptom cluster of the anorexia-cachexia syndrome.  The anorexia-cachexia symptom cluster includes cachexia (anorexia, weight loss and muscle wasting), fatig
'/>"/>

SOURCE Vicus Therapeutics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics Records Last Patient Visit of Phase 2, VT-122 Trial for the Treatment of Cachexia in Patients With Advanced Lung Cancer
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY®
4. PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis
5. Silence Therapeutics Provides Year-end Update
6. Angelica Therapeutics Receives a $244,479 Qualified Therapeutic Discovery Project Grant for Its Anti-Cancer Drug
7. Talecris Biotherapeutics Enrolls Patients in Clinical Trial Evaluating Two Doses of PROLASTIN®-C
8. Osseon® Therapeutics Names Gary Coughlen, CPA as New Chief Financial Officer
9. Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinsons Disease
10. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
11. Nile Therapeutics Receives NASDAQ Notice; Will Request Hearing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... JUNCTION, N.J. , May 4, 2015 /PRNewswire/ ... care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine ... in multiple countries worldwide, will report Q1 2015 ... May 11, 2015.  CytoSorbents, management ... webcast that will recount both operational and financial ...
(Date:5/4/2015)... -- Concord Medical Services Holdings Limited ("CCM" or the "Company") ... provider and operator of the largest network of radiotherapy and ... today that an Extraordinary General Meeting ("EGM") will be held ... time) at CCM,s office at 18/F, Tower A, ... District, Beijing, P.R. China . ...
(Date:5/4/2015)... /PRNewswire/ - YOLO Medical Inc. , ("YOLO") ... of medical and aesthetic devices, proudly announces that ... new generation body contouring laser system; LIPOFINA. ... low-level laser device for body contouring, creating and ... technology while continuing to push the envelope of ...
Breaking Medicine Technology:CytoSorbents to Report Q1 2015 Operating and Financial Results 2CytoSorbents to Report Q1 2015 Operating and Financial Results 3Concord Medical Services Announces 2015 Extraordinary General Meeting of Shareholders 2YOLO Medical Inc. receives FDA clearance for body contouring laser 2
(Date:5/4/2015)... (PRWEB) May 04, 2015 Sheltering Arms ... Center from Hale House. The Mother Hale Learning Center ... affordable Early Childhood Education. Sheltering Arms will begin operating ... to be served by the center. , Opened in ... ages six weeks to five years, many of whom ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Dr. Richard ... has been chosen to receive the America’s Best Dentist ... Dr. Champagne’s selection as a top dentist is a ... to continuing education and his compassion for his patients. ... professionals who exemplify excellence in their field. These nominees ...
(Date:5/4/2015)... Scanmarket, a leading provider of strategic sourcing ... the just-released Spend Matters “50 to Know” listing for ... 50 To Know " listing is a great honor ... providing comprehensive, easy-to-use strategic sourcing solutions to our customers”, ... well-established and respected companies on this list, and while ...
(Date:5/4/2015)... St. Louis, Missouri (PRWEB) May 04, 2015 ... been recognized as the “Gateway to the West,” so ... its “Gateway for Veterans Program”, says Dr. Ben Litalien, ... the International Franchise Association’s VetFran program and will provide ... , Zerorez® is proud to have a ...
(Date:5/3/2015)... Clarkston, Metamora, Michigan (PRWEB) May 03, 2015 ... ‘Like’ mark on their Facebook page. , ... patients on the many services the Practice has, it’s ... current events. , Women’s Excellence has a very strong ... +, Pinterest, Instagram and You Tube. , Women’s ...
Breaking Medicine News(10 mins):Health News:Sheltering Arms Acquires the Mother Hale Learning Center 2Health News:New Jersey Dentist Dr. Richard Champagne Nominated for America’s Best Dentist Award 2Health News:Scanmarket Selected to Spend Matters "50 To Know" List of Companies in Procurement Sector. 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 3
... drugs to enhance traits that are not fundamental to their ... Journal of Consumer Research, people,s willingness to take a ... promises to enhance is one they consider fundamental. , Authors ... University), and Geoffrey P. Goodwin (Princeton University) examine the moral ...
... likely to reuse hotel towels if they know other ... in the Journal of Consumer Research examined ... reduce unnecessary laundering. Authors Noah J. Goldstein (University of ... State University) found that the types of signs posted ...
... Eat Right, Move More and ... Milk Their Diets, BIRMINGHAM, Ala., Aug. ... different fad diets -- which seem to go in,and out of fashion like ... Americans -- including 25 percent of,Alabama residents -- remain overweight or obese., ...
... Company Reports Three-Year Sales Growth of 320% , ... ... -- Inc. today ranked CollaborateMD, a leading provider of Internet ... the healthcare industry, http://www.inc.com/inc5000/2008/company-profile.html?id=200811730 [No. 1173] on its ...
... Chairman Robert M. "Mike" Duncan released the following,statement ... "While Barack Obama campaigns on expanding health care, ... people away from care at the,University of Chicago ... rhetoric not matching his record and raises serious ...
... Class Action Lawsuit, SEATTLE, Aug. 22, A ... County Superior Court,against Milwaukee-based Extendicare Homes, Inc., Fir Lane ... facilities,in the state of Washington [see list by city ... the personal representative for the estate of Lee Ann,Steele ...
Cached Medicine News:Health News:Healthy people and enhancement drugs 2Health News:A room with a viewpoint: conservation messages and motivation 2Health News:Message to Birmingham Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Birmingham Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:CollaborateMD Ranks in Top 100 Software Companies on 2008 Inc. 5,000 2Health News:CollaborateMD Ranks in Top 100 Software Companies on 2008 Inc. 5,000 3Health News:RNC Statement Obama and Health Care 2Health News:More Legal Trouble for Elder Care Operator 2Health News:More Legal Trouble for Elder Care Operator 3Health News:More Legal Trouble for Elder Care Operator 4
... CTi Wrist is a custom wrist orthotic designed to ... patient's maximum range-of-motion. , ,Indications: , Wrist ... fibrocartilage complex , Coles fracture - distal ... Partial tendon rupture , ORIF - Open ...
The Contoured Wrist/Forearm Support provides comfort for post-surgical immobilization, post-fracture casting, and wrist sprains and strains....
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
ManuTrain is an active wrist support that has optional features for increased stabilization....
Medicine Products: